The role of cerebellum in unipolar and bipolar depression: A review of the main neurobiological findings

Rivista di Psichiatria

Volumn 49, Issue 3, 2014, Pages 124-131

  Minichino, Amedeo ^a   Bersani, Francesco Saverio ^a,b   Trabucchi, Guido ^a   Albano, Gabriella ^b   Primavera, Martina ^a   Chiaie, Roberto Delle ^a   Biondi, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bipolar depression; Cerebellum; Neuroimaging; Unipolar depression

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; TRANSCRIPTION FACTOR SP4;

ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CEREBELLUM; FUNCTIONAL NEUROIMAGING; HUMAN; MAJOR DEPRESSION; MITOCHONDRION; NEUROBIOLOGY; PATHOPHYSIOLOGY; DEPRESSION; EMOTION; PHYSIOLOGY;

BIPOLAR DISORDER; CEREBELLUM; DEPRESSIVE DISORDER; EMOTIONS; FUNCTIONAL NEUROIMAGING; HUMANS;

EID: 84903646188     PISSN: 00356484     EISSN: 20382502     Source Type: Journal    
DOI: None     Document Type: Article

References (116)

1. Schmahmann JD. Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367-78.
2. Rapoport M, Van Reekum R, Mayberg H. The role of the cerebellum in cognition and behavior: A selective review. J Neuropsychiatry Clin Neurosci 2000; 12: 193-8.
3. Anand BK, Malhotra CL, Singh B, Dua S. Cerebellar projections to limbic system. J Neurophysiol 1959; 22: 451-7.
4. Schutter DJ, Van Honk J. The cerebellum in emotion regulation: A repetitive transcranial magnetic stimulation study. Cerebellum 2009; 8: 28-34.
5. Schutter DJ, Van Honk J. The cerebellum on the rise in human emotion. Cerebellum 2005; 4: 290-4.
6. Moret C, Briley M. The importance of norepinephrine in depression. Neuropsychiatr Dis Treat 2011; 7: 9-13.
7. Yatham LN, Malhi GS. Neurochemical brain imaging studies in bipolar disorder. Acta Neuropsychiatrica 2003; 15: 381-7.
8. Nashold BS Jr, Slaughter DG. Effects of stimulating or destroying the deep cerebellar regions in man. J Neurosurg 1969; 31: 172-86.
9. Riklan M, Cullinan T, Cooper IS. Tension reduction and alerting in man following chronic cerebellar stimulation for the relief of spasticity or intractable seizures. J Nerv Ment Dis 1977; 164: 176-81.
10. Heath RG, Rouchell AM, Llewellyn RC, Walker CF. Cerebellar pacemaker patients: An update. Biol Psychiatry 1981; 16: 953-62.
11. Schweighofer N, Doya K, Kuroda S. Cerebellar aminergic neuromodulation: Towards a functional understanding. Brain Res Brain Res Rev 2004; 44: 103-16.
12. Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: A meta-analysis of neuroimaging studies. Neuroimage 2009; 44: 489-501.
13. Exner C, Weniger G, Irle E. Cerebellar lesions in the PICA but not SCA territory impair cognition. Neurology 2004; 63: 2132-5.
14. Tavano A, Grasso R, Gagliardi C, et al. Disorders of cognitive and affective development in cerebellar malformations. Brain 2007; 130: 2646-60.
15. Schmahmann JD, Macmore J, Vangel M. Cerebellar stroke without motor deficit: Clinical evidence for motor and non-motor domains within the human cerebellum. Neuroscience 2009; 162: 852-61.
16. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998; 121: 561-79.
17. Lewinsohn P, Klein D, Seeley J. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995; 34: 454-63.
18. Pini S, Preve M. Approach to bipolar spectrum and subthreshold mood disorders. Riv Psichiatr 2011; 46: 233-41.
19. Delle Chiaie R, Trabucchi G, Girardi N, et al. Group psychoeducation normalizes cortisol awakening response in stabilized bipolar patients under pharmacological maintenance treatment. Psychother Psychosom 2013; 82: 264-6.
20. Bersani G, Marino P, Valeriani G, et al. Manic-like psychosis associated with elevated trough tacrolimus blood concentrations 17 years after kidney transplant. Case Rep Psychiatry 2013; 2013: 926395. doi: 10.1155/2013/926395.
21. Strakowski SM, Adler CM, Almeida J, et al. The functional neuroanatomy of bipolar disorder: A consensus model. Bipolar Disord 2012; 14: 313-25.
22. Bersani FS, Iannitelli A, Pacitti F, Bersani G. Sleep and biorhythm disturbances in schizophrenia, mood and anxiety disorders: A review. Riv Psichiatr 2012; 47: 365-75.
23. Salviati M, Bersani FS, Macrì F, et al. Capgras-like syndrome in a patient with an acute urinary tract infection. Neuropsychiatr Dis Treat 2013; 9: 139-42.
24. Lauterbach EC. Bipolar disorders, dystonia, and compulsion after dysfunction of the cerebellum, dentatorubrothalamic tract, and substantia nigra. Biol Psychiatry 1996; 40: 726-30.
25. Soares JC, Mann JJ. The anatomy of mood disorders: Review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86-106.
26. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: A pilot study. Neuropsychopharmacology 1999; 21: 63-8.
27. Brambilla P, Harenski K, Nicoletti M, et al. MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res 2001; 35: 313-22.
28. Mills NP, DelBello MP, Adler CM, Strakowski SM. MRI analysis of cerebellar vermal abnormalities in bipolar disorder. Am J Psychiatry 2005; 162: 1530-2.
29. Monkul ES, Hatch JP, Sassi RB, et al. MRI study of the cerebellum in young bipolar patients. Prog Neuropsychopharm Biol Psychiatry 2008; 32: 613-9.
30. Ketter TA, Kimbrell TA, George MS, et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001; 49: 97-109.
31. Mah L, Zarate CA Jr, Singh J, et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry 2007; 61: 765-75.
32. Malhi GS, Lagopoulos J, Owen AM, Ivanovski B, Shnier R, Sachdev P. Reduced activation to implicit affect induction in euthymic bipolar patients: An fMRI study. J Affect Disord 2007; 97: 109-22.
33. Strakowski SM, Adler CM, Holland SK, Mills NP, DelBello MP, Eliassen JC. Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. Am J Psychiatry 2005; 162: 1697-05.
34. Loeber RT, Sherwood AR, Renshaw PF, Cohen BM, Yurgelun-Todd DA. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophr Res 1999; 37: 81-9.
35. Benson BE, Willis MW, Ketter TA, et al. Interregional cerebral metabolic associativity during a continuous performance task (Part II): Differential alterations in bipolar and unipolar disorders. Psychiatry Res 2008; 164: 30-47.
36. Horwitz B. The elusive concept of brain connectivity. Neuroimage 2003; 19: 466-70.
37. Kimbrell TA, Ketter TA, George MS, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 2002; 51: 237-52.
38. Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive tran-scranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999; 46: 1603-13.
39. McQueen MB, Devlin B, Faraone SV, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 2005; 77: 582-95.
40. Choi KH, Elashoff M, Higgs BW, et al. Putative psychosis genes in the prefrontal cortex: Combined analysis of gene expression microarrays. BMC Psychiatry 2008; 8:87.
41. Shi J, Potash JB, Knowles JA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2011; 16: 193-201.
42. Tam GW, Van de Lagemaat LN, Redon R, et al. Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem Soc Trans 2010; 38: 445-51.
43. Ben-Shachar D, Karry R. Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS ONE 2007; 2: E817.
44. Heintz N. Gene expression nervous system atlas (GENSAT). Nat Neurosci 2004; 7: 483.
45. Zhu H, Nguyen VT, Brown AB, et al. A novel, tissuerestricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b MEF-2) in the rat myosin light-chain 2 gene. Mol Cell Biol 1993; 13: 4432-44.
46. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 2002; 195: 27-38.
47. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001; 188: 143-60.
48. Pinacho R, Villalmanzo N, Lalonde J, et al. The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: Control by epolarization and lithium Bipolar Disord 2011; 13: 474-85.
49. Fatemi SH, Reutiman TJ, Folsom TD. The role of lithium in modulation of brain genes: Relevance for aetiology and treatment of bipolar disorder. Biochem Soc Trans 2009; 37: 1090-5.
50. Chetcuti A, Adams LJ, Mitchell PB, Schofield PR. Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment. Psychiatr Genet 2008; 18: 64-72.
51. Washizuka S, Kametani M, Sasaki T, et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 301-4.
52. Kato T, Kunugi H, Nanko S, Kato N. Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord 2001; 62: 151-64.
53. Martorell L, Segues T, FolchG, et al. New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet 2006; 14: 520-8.
54. McMahon FJ, Chen YS, Patel S, et al. Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry 2000; 157: 1058-64.
55. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004; 61: 300-8.
56. Vawter MP, Tomita H, Meng F, et al. Mitochondrial related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders. Mol Psychiatry 2006; 11: 615, 663-79.
57. Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study. Biol Psychiatry 2004; 55: 676-84.
58. Ben-Shachar D, Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS ONE 2008; 3: E3676.
59. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Prog Neurobiol 2005; 76: 99-125.
60. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 2010; 70: 271-88.
61. Ohira K, Hayashi M. A new aspect of the TrkB signaling pathway in neural plasticity. Curr Neuropharmacol 2009; 7: 276-85.
62. Bersani G, Iannitelli A, Massoni E, et al. Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects. Int J Immunopathol Pharmacol 2004; 17: 367-72.
63. Aloe L, Iannitelli A, Angelucci F, Bersani G, Fiore M. Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders. Behav Pharmacol 2000; 11: 235-42.
64. Bersani G, Iannitelli A, Fiore M, Angelucci F, Aloe L. Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. Med Hypotheses 2000; 55: 199-207.
65. Aloe L, Iannitelli A, Bersani G, et al. Haloperidol administration in humans lowers plasma nerve growth factor level: Evidence that sedation induces opposite effects to arousal. Neuropsychobiology 1997; 36: 65-8.
66. Tirassa P, Iannitelli A, Sornelli F, et al. Daily serum and salivary BDNF levels correlate with morning-evening personality type in women and are affected by light therapy. Riv Psichiatr 2012; 47: 527-34.
67. Luberg K, Wong J, Weickert CS, Timmusk T. Human TrkB gene: Novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem 2010; 113: 952-64.
68. Ohira K, Hayashi M. Expression of TrkB subtypes in the adult monkey cerebellar cortex. J Chem Neuroanat 2003; 25: 175-83.
69. Sherrard RM, Dixon KJ, Bakouche J, Rodger J, Lemaigre-Dubreuil Y, Mariani J. Differential expression of TrkB isoforms switches climbing fiber-Purkinje cell synaptogenesis to selective synapse elimination. Dev Neurobiol 2009; 69: 647-62.
70. Soontornniyomkij B, Everall IP, Chana G, Tsuang MT, Achim CL, Soontornniyomkij V. Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder. J Affect Disord 2011; 133: 646-54.
71. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 2001; 12: 3257-62.
72. Gray LJ, Dean B, Kronsbein HC, Robinson PJ, Scarr E. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder. Psychiatry Res 2010; 178: 374-80.
73. Lepine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat 2011; 7: 3-7.
74. Bersani G, Bersani FS, Prinzivalli E, et al. Premorbid circadian profile of patients with major depression and panic disorder. Riv Psichiatr 2012; 47: 407-12.
75. Bersani G, Meco G, Denaro A, et al. L-acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetine. Eur Neuropsychopharmacol 2013; 23: 1219-25.
76. Costantini A, Picardi A, Brunetti S, et al. [Italian version of Demoralization Scale: A validation study]. Riv Psichiatr 2013; 48: 234-39.
77. Hernaez-Goni P, Tirapu-Ustarroz J, Iglesias-Fernández L, Luna-Lario P. [The role of the cerebellum in the regulation of affection, emotion and behaviour]. Rev Neurol 2010; 51: 597-09.
78. Shah SA, Doraiswamy PM, Husain MM, et al. Posterior fossa abnormalities in major depression: A controlled magnetic resonance imaging study. Acta Psychiatr Scand 1992; 85: 474-9.
79. Escalona PR, Early B, McDonald WM. Reduction of cerebellar volume in major depression: A controlled magnetic resonance imaging study. Depression 1993; 1: 156-8.
80. Pillay SS, Yurgelun-Todd DA, Bonello CM, Lafer B, Fava M, Renshaw PF. A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity. Biol Psychiatry 1997; 42: 79-84.
81. Lee HY, Tae WS, Yoon HK, et al. Demonstration of decreased gray matter concentration in the midbrain encompassing the dorsal raphe nucleus and the limbic subcortical regions in major depressive disorder: An optimized voxel-based morphometry study. J Affect Disord 2011; 133: 128-36.
82. Peng J, Liu J, Nie B, et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: A voxel-based morphometry study. Eur J Radiol 2011; 80: 395-9.
83. Sassi RB, Soares JC. Ressonância magnética estrutural nos transtornos afetivos. Rev Bras Psiquiatr 2001; 23: 11-4.
84. Middleton FA, Strick PL. Cerebellar projections to the prefrontal cortex of the primate. J Neurosci 2001; 21: 700-12.
85. Dolan RJ, Bench CJ, Brown RG, et al. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 1992; 55: 768-73.
86. Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 2008; 29: 683-95.
87. Smith KA, Ploghaus A, Cowen PJ, et al. Cerebellar responses during anticipation of noxious stimuli in subjects recovered from depression. Functional magnetic resonance imaging study. Br J Psychiatry 2002; 181: 411-5.
88. Liu Z, Xu C, Xu Y, et al. Decreased regional homogeneity in insula and cerebellum: A resting-state fMRI study in patients with major depression and subjects at high risk for major depression. Psychiatry Res 2010; 182: 211-5.
89. Gonul AS, Kula M, Bilgin AG, Tutus A, Oguz A. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1015-21.
90. Bersani G, Clemente R, Gherardelli S, Bersani FS, Manuali G. Obstetric complications and neurological soft signs in male patients with schizophrenia. Acta Neuropsychiatr 2012; 24: 344-8.
91. Dichter GS, Kozink RV, McClernon FJ, Smoski MJ. Remitted major depression is characterized by reward network hyperactivation during reward anticipation and hypoactivation during reward outcomes. J Affect Disord 2012; 136: 1126-34.
92. Schmahmann, JD. The role of the cerebellum in cognition and emotion: Personal reflections since 1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev 2010; 20: 236-60.
93. Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA. Cerebellar blood volume in bipolar patients correlates with medication. Biol Psychiatry 2002; 51: 370-6.
94. Miller DD, Rezai K, Alliger R, Andreasen NC. The effect of antipsychotic medication on relative cerebral perfusion in schizophrenia (Assessment with technetium-99 m hexamethyl-propyleneamine oxime single photon emission computed tomography). Biol Psychiatry 1997; 41: 550-9.
95. Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-12.
96. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Melzer H, Ovesholser J, Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 2002; 57: 127-38.
97. Cotter D, Mackay O, Landau S, Kerwin R, Everall T. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58: 545-53.
98. Patanow CM, Day JR, Billingsley ML. Alterations in hippocampal expression of SNAP-25, GAP-43, stanin and glial fibrillary acidic protein following mechanical and trimethylene-induced injury in the rat. Neuroscientist 1997; 76: 187-202.
99. Montgomery DL. Astrocytes: Form, functions, and roles in disease. Vet Pathol 1994; 31: 145-67.
100. Coyle JT, Schwarcz R. Mind glue, implications of glial cell biology for psychiatry. Arch Gen Psychiatry 2000; 57: 90-3.
101. Fatemi SH, Emanian ES, Sidwell RW, et al. Human influenzal viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 2002; 7: 633-40.
102. Fatemi SH, Laurence J, Araghi-Niknam M, Rizvi S, Stary JM, Realmuto GR. Glial fibrillary acidic protein is elevated in superior frontal and parietal cortices of autistic subjects. Int J Neuropsychopharmacol 2002; 5: 163-4.
103. Moises HW, Zoega T, Gottesman II. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002; 2:8.
104. Bersani FS, Capra E, Minichino A, et al. Factors affecting interindividual differences in clozapine response: A review and case report. Hum Psychopharmacol 2011; 26: 177-87.
105. Pannese R, Minichino A, Pignatelli M, Delle Chiaie R, Biondi M, Nicoletti F. Evidences on the key role of the metabotrobic glutamatergic receptors in the pathogenesis of schizophrenia: A "breakthrough" in pharmacological treatment. Riv Psichiatr 2012; 47: 149-69.
106. Heath RG, Franklin D, Shraberg D. Gross pathology of the cerebellum in patients diagnosed and treated as functional psychiatric disorders. J Nerv Ment Dis 1979; 167: 585-92.
107. Heath RG. Modulation of emotion with a brain pacemaker: Treatment for intractable psychiatric illness. J Nerv Ment Dis 1977; 165: 300-17.
108. Minichino A, Bersani FS, Capra E, et al. ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: A comparative review. Neuropsychiatr Dis Treat 2012; 8: 55-64.
109. Bersani FS, Biondi M. Historical recurrences in psychiatry: Somatic therapies. Riv Psichiatr 2012; 47: 1-4.
110. Bersani FS, Minichino A, Enticott PG, et al. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review. Eur Psychiatry 2013; 28: 30-9.
111. Rapinesi C, Kotzalidis GD, Serata D, et al. Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: Three case reports. Prim Care Companion CNS Disord 2013 doi: 10.4088/PCC.12m01438
112. Bersani FS, Girardi N, Sanna L, et al. Deep Transcranial Magnetic Stimulation for treatment-resistant bipolar depression: A case report of acute and maintenance efficacy. Neurocase 2013; 19: 451-7.
113. Schutter DJ, Van Honk J. An electrophysiological link between the cerebellum, cognition and emotion: Frontal theta EEG activity to single-pulse cerebellar TMS. Neuroimage 2006; 33: 1227-31.
114. Reiman E, Raichle M, Robins E, et al. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 1989; 46: 493-500.
115. Gundel H, O'Connor MF, Littrell L, Fort C, Lane RD. Functional neuroanatomy of grief: An fMRI study. Am J Psych 2003; 160: 1946-53.
116. Demirtas-Tatlidede A, Freitas C, Cromer JR, et al. Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia. Schizophr Res 2010; 124: 91-100.